BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38461339)

  • 1. Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.
    Robinson RH; Meissler JJ; Breslow-Deckman JM; Gaughan J; Adler MW; Eisenstein TK
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1239-50. PubMed ID: 23824763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of CacyBP/SIP, β-catenin and cannabinoid receptors in the adrenals of hypertensive rats.
    Smereczańska M; Domian N; Lewandowska A; Kasacka I
    J Cell Mol Med; 2024 May; 28(10):e18376. PubMed ID: 38780511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.
    Schlienz NJ; Budney AJ; Lee DC; Vandrey R
    Curr Addict Rep; 2017 Jun; 4(2):75-81. PubMed ID: 29057200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthetic CB
    Coronado-Álvarez A; Romero-Cordero K; Macías-Triana L; Tatum-Kuri A; Vera-Barrón A; Budde H; Machado S; Yamamoto T; Imperatori C; Murillo-Rodríguez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110301. PubMed ID: 33741446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
    Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI
    Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
    Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
    Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
    Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
    Tambaro S; Casu MA; Mastinu A; Lazzari P
    Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.
    Ibrahim MM; Deng H; Zvonok A; Cockayne DA; Kwan J; Mata HP; Vanderah TW; Lai J; Porreca F; Makriyannis A; Malan TP
    Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10529-33. PubMed ID: 12917492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Polypharmacological Effects of Cannabidiol.
    Castillo-Arellano J; Canseco-Alba A; Cutler SJ; León F
    Molecules; 2023 Apr; 28(7):. PubMed ID: 37050032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer.
    Ucaryilmaz Metin C; Ozcan G
    BMC Cancer; 2022 Jun; 22(1):692. PubMed ID: 35739492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Cannabis and Utilization of Nonhospice Palliative Care Services: Complements and Alternatives at End of Life.
    Croker JA; Bobitt J; Arora K; Kaskie B
    Innov Aging; 2022; 6(1):igab048. PubMed ID: 35047709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological mechanisms of cancer-induced bone pain.
    Zheng XQ; Wu YH; Huang JF; Wu AM
    J Adv Res; 2022 Jan; 35():117-127. PubMed ID: 35003797
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.